Immunization with more than one immunogen (coimmunization) is an efficient regimen to induce immunity to multiple antigens. However, immune interference has been reported using multi-plasmid DNA immunizations (e.g. co-immunization using HIV-1 Gag-Pol p160 and Vpr). HIV-1 envelope (Env) and Gag gene products are the most predominant immunogens used in current AIDS vaccines, although, few studies have evaluated possible immune interference when these two antigens are coadministered. Therefore, in this study, immune interference during co-inoculation was examined using DNA vaccines expressing Env gp120 and Gag p55 from gene sequences optimized for efficient expression in mammalian cells (codon-optimized). BALB/c mice vaccinated with each plasmid individually elicited high titer immune responses, however, when these same plasmids were coinoculated, there was a reduction in the immunity elicited to Gag p55 . In contrast, anti-Env gp120 immunity was not affected. To determine if the anti-Gag immune interference was specific to Env, mice were co-immunized with plasmids expressing a soluble form of hemagglutinin (sHA) from influenza virus (A/PR/8/34) and Gag p55 -DNA. Similar titers of anti-Gag p55 immunity were observed in mice co-immunized with sHA-DNA and Gag p55 -DNA, as mice vaccinated with Gag p55 -DNA only. Gag p55 -DNA co-immunization did not affect anti-Env gp120 or anti-sHA immune responses. The Env gp120 /Gag p55 immune interference elicited during co-immunizations was not dependent on the amount of protein expressed. In addition, this induced immune interference was observed in mice even when the immunizations were performed in separate locations. Therefore, Env gp120 specifically interferes with the elicitation of anti-Gag p55 immune responses following co-immunization. Since Env and Gag are the most commonly used HIV-1 antigens in AIDS vaccine designs, future vaccine development should consider the effect of each immunogen during evaluation of the effectiveness of AIDS vaccines. [link 'here' using 'a href' to: <url>http://www.biomedcentral.com/content/pdf/1742-4690-2-S1-full.pdf</url>]</note> </supplement>
